For the twelve months ended Aug 1, 2026, Petco Health and Wellness Company Inc. reported $5.97B of revenue and $30.27M of net income.
WOOF revenue was $1.49B in fiscal Q2 2026 (ended Aug 1, 2026), up 0.0% from a year earlier and down 0.5% from the prior quarter. For the full fiscal 2025 it was $5.96B, down 2.5% from fiscal 2024. Compound annual growth was +3.9% over 5 years. It rose in 4 of the last 6 fiscal years.
WOOF net income was $38.66M in fiscal Q2 2026 (ended Aug 1, 2026), up 176.7% from a year earlier. For the full fiscal 2025 it was $9.07M, compared with -$101.82M in fiscal 2024.
WOOF diluted EPS was $0.13 in fiscal Q2 2026 (ended Aug 1, 2026), up 160.0% from a year earlier. For the full fiscal 2025 it was $0.03, compared with -$0.37 in fiscal 2024.
WOOF free cash flow was $129.92M in fiscal Q2 2026 (ended Aug 1, 2026), up 141.5% from a year earlier. For the full fiscal 2025 it was $186.95M, up 276.3% from fiscal 2024. Compound annual growth was +11.4% over 5 years. Fiscal 2025 is the highest of the 7 fiscal years on file.
| Line item | Jan 31, 2026 | Feb 1, 2025 | Feb 3, 2024 | Jan 28, 2023 | Jan 29, 2022 | Jan 30, 2021 | Feb 1, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $5.96B | $6.12B | $6.26B | $6.04B | $5.81B | $4.92B | $4.43B |
| Cost of revenue | $3.66B | $3.79B | $3.90B | $3.61B | $3.38B | $2.81B | $2.53B |
| Gross profit | $2.31B | $2.32B | $2.35B | $2.43B | $2.43B | $2.11B | $1.91B |
| Selling, general and admin | $2.18B | $2.32B | $2.31B | $2.20B | $2.16B | $1.91B | $1.78B |
| Operating income | $120.43M | $7.05M | -$1.18B | $225.56M | $266.07M | $194.42M | $110.60M |
| Interest expense | $131.20M | $143.53M | $150.91M | $101.64M | $77.40M | $219.08M | $253.02M |
| Pre-tax income | $15.33M | -$109.30M | -$1.31B | $112.28M | $202.40M | -$41.55M | -$142.08M |
| Income tax | $6.27M | -$7.48M | -$27.61M | $35.35M | $53.47M | -$3.34M | -$35.66M |
| Net income | $9.07M | -$101.82M | -$1.28B | $90.80M | $164.42M | -$26.48M | -$95.87M |
| EPS, basic | $0.03 | -$0.37 | -$4.78 | $0.34 | $0.62 | -$0.13 | -$0.46 |
| EPS, diluted | $0.03 | -$0.37 | -$4.78 | $0.34 | $0.62 | -$0.13 | -$0.46 |
| Diluted shares | 286.1M | 273.4M | 267.5M | 266.0M | 265,338 | 210,683 | 208,933 |
| Line item | Jan 31, 2026 | Feb 1, 2025 | Feb 3, 2024 | Jan 28, 2023 | Jan 29, 2022 | Jan 30, 2021 | Feb 1, 2020 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $256.74M | $181.66M | $136.65M | $213.73M | $221.89M | $119.54M | $154.72M |
| Receivables | $45.81M | $40.42M | $44.37M | $49.58M | $55.62M | $41.83M | - |
| Inventory | $590.21M | $653.33M | $684.50M | $652.43M | $675.11M | $538.67M | - |
| Current assets | $1.02B | $973.62M | $951.74M | $1.02B | $1.07B | $777.55M | - |
| Goodwill | $980.06M | $980.06M | $980.30M | $2.19B | $2.18B | $2.18B | $2.18B |
| Total assets | $5.17B | $5.19B | $5.36B | $6.61B | $6.50B | $6.08B | - |
| Current liabilities | $1.13B | $1.14B | $1.11B | $1.02B | $1.05B | $875.31M | - |
| Long-term debt | $1.49B | $1.58B | $1.58B | $1.63B | $1.64B | $1.65B | - |
| Total debt | $1.49B | $1.58B | $1.58B | $1.63B | $1.64B | $1.65B | - |
| Total liabilities | $4.01B | $4.08B | $4.18B | $4.23B | $4.24B | $4.02B | - |
| Shareholders' equity | $1.16B | $1.11B | $1.18B | $2.38B | $2.26B | $2.06B | $561.06M |
| Line item | Jan 31, 2026 | Feb 1, 2025 | Feb 3, 2024 | Jan 28, 2023 | Jan 29, 2022 | Jan 30, 2021 | Feb 1, 2020 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $314.05M | $177.67M | $215.72M | $346.00M | $358.21M | $268.62M | $110.34M |
| Capital expenditures | $127.10M | $127.99M | $225.60M | $278.02M | $239.11M | $159.56M | $156.91M |
| Free cash flow | $186.95M | $49.68M | -$9.88M | $67.98M | $119.11M | $109.06M | -$46.57M |
| Investing cash flow | -$124.56M | -$123.90M | -$207.44M | -$320.32M | -$237.08M | -$157.19M | -$139.04M |
| Financing cash flow | -$101.75M | -$8.75M | -$85.35M | -$33.84M | -$18.78M | -$146.61M | -$3.07M |
| Stock-based compensation | $32.65M | $50.21M | $81.86M | $60.78M | $49.27M | $12.91M | $9.49M |
| Depreciation and amortization | $196.71M | $208.52M | $203.62M | $193.83M | $172.43M | $174.84M | $173.54M |
| Line item | Jan 31, 2026 | Feb 1, 2025 | Feb 3, 2024 | Jan 28, 2023 | Jan 29, 2022 | Jan 30, 2021 | Feb 1, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -2.5% | -2.2% | 3.6% | 3.9% | 18.0% | 11.0% | - |
| Net income growth, YoY | - | - | - | -44.8% | - | - | - |
| Gross margin | 38.7% | 38.0% | 37.6% | 40.2% | 41.8% | 42.8% | 43.0% |
| Operating margin | 2.0% | 0.1% | -18.9% | 3.7% | 4.6% | 4.0% | 2.5% |
| Net margin | 0.2% | -1.7% | -20.5% | 1.5% | 2.8% | -0.5% | -2.2% |
| Free cash flow margin | 3.1% | 0.8% | -0.2% | 1.1% | 2.1% | 2.2% | -1.1% |
| Return on equity | 0.8% | -9.1% | -108.1% | 3.8% | 7.3% | -1.3% | -17.1% |
| Return on assets | 0.2% | -2.0% | -23.9% | 1.4% | 2.5% | -0.4% | - |
| Current ratio | 0.90 | 0.85 | 0.86 | 0.99 | 1.02 | 0.89 | - |
| Debt to equity | 1.28 | 1.42 | 1.33 | 0.68 | 0.73 | 0.80 | - |
| Line item | Aug 1, 2026 | May 2, 2026 | Jan 31, 2026 | Nov 1, 2025 | Aug 2, 2025 | May 3, 2025 | Feb 1, 2025 | Nov 2, 2024 | Aug 3, 2024 | May 4, 2024 | Feb 3, 2024 | Oct 28, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.50B | $1.52B | $1.46B | $1.49B | $1.49B | $1.55B | $1.51B | $1.52B | $1.53B | $1.67B | $1.49B |
| Cost of revenue | $898.07M | $922.31M | $934.36M | $895.40M | $903.21M | $923.43M | $962.87M | $935.68M | $943.03M | $950.48M | $1.07B | $944.16M |
| Gross profit | $591.15M | $574.42M | $580.77M | $569.01M | $585.32M | $569.97M | $589.26M | $575.76M | $580.73M | $578.66M | $606.35M | $550.00M |
| Selling, general and admin | $543.34M | $549.80M | $548.91M | $539.82M | $542.30M | $553.61M | $571.87M | $571.78M | $578.26M | $595.44M | $606.18M | $559.61M |
| Operating income | $47.81M | $24.63M | $31.86M | $29.20M | $43.02M | $16.36M | $17.39M | $3.98M | $2.47M | -$16.78M | $166.0K | -$1.23B |
| Interest expense | $32.56M | $32.78M | $31.58M | $32.83M | $33.30M | $33.49M | $34.11M | $35.80M | $36.80M | $36.82M | $39.66M | $36.56M |
| Pre-tax income | $17.75M | -$18.50M | $22.29M | -$1.82M | $10.63M | -$15.78M | $2.22M | -$22.01M | -$33.66M | -$55.85M | -$22.98M | -$1.27B |
| Income tax | -$15.71M | $2.20M | $11.30M | -$6.28M | $746.0K | $495.0K | $2.50M | -$857.0K | -$4.65M | -$4.48M | -$10.44M | -$22.90M |
| Net income | $38.66M | -$15.15M | -$2.58M | $9.33M | $13.97M | -$11.66M | -$13.84M | -$16.67M | -$24.82M | -$46.48M | -$22.57M | -$1.24B |
| EPS, basic | $0.14 | -$0.05 | -$0.01 | $0.03 | $0.05 | -$0.04 | -$0.05 | -$0.06 | -$0.09 | -$0.17 | - | -$4.63 |
| EPS, diluted | $0.13 | -$0.05 | -$0.01 | $0.03 | $0.05 | -$0.04 | -$0.05 | -$0.06 | -$0.09 | -$0.17 | - | -$4.63 |
| Diluted shares | 290.5M | 283.7M | - | 288.2M | 285.7M | 277.5M | - | 274.5M | 273.1M | 269.8M | - | 267.9M |
| Line item | Aug 1, 2026 | May 2, 2026 | Jan 31, 2026 | Nov 1, 2025 | Aug 2, 2025 | May 3, 2025 | Feb 1, 2025 | Nov 2, 2024 | Aug 3, 2024 | May 4, 2024 | Feb 3, 2024 | Oct 28, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $293.50M | $166.80M | $256.74M | $237.41M | $189.73M | $138.74M | $181.66M | $121.02M | $133.65M | $90.86M | $136.65M | $142.23M |
| Receivables | $38.39M | $36.93M | $45.81M | $42.90M | $34.52M | $36.08M | $40.42M | $40.43M | $47.03M | $42.08M | $44.37M | $50.18M |
| Inventory | $601.59M | $632.91M | $590.21M | $617.90M | $608.51M | $645.47M | $653.33M | $690.29M | $672.33M | $681.02M | $684.50M | $730.15M |
| Current assets | $1.05B | $960.84M | $1.02B | $1.01B | $939.56M | $920.43M | $973.62M | $931.78M | $941.89M | $904.05M | $951.74M | $1.01B |
| Goodwill | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.30M | $976.25M |
| Total assets | $5.17B | $5.08B | $5.17B | $5.21B | $5.15B | $5.12B | $5.19B | $5.21B | $5.28B | $5.26B | $5.36B | $5.43B |
| Current liabilities | $1.17B | $1.13B | $1.13B | $1.10B | $1.06B | $1.08B | $1.14B | $1.11B | $1.12B | $1.07B | $1.11B | $1.11B |
| Long-term debt | - | - | $1.49B | $1.58B | $1.58B | $1.58B | $1.58B | $1.58B | $1.58B | $1.57B | $1.58B | $1.57B |
| Total debt | - | - | $1.49B | $1.58B | $1.58B | $1.58B | $1.58B | $1.58B | $1.58B | $1.57B | $1.58B | $1.57B |
| Total liabilities | $3.96B | $3.93B | $4.01B | $4.05B | $4.01B | $4.01B | $4.08B | $4.09B | $4.15B | $4.10B | $4.18B | $4.23B |
| Shareholders' equity | $1.21B | $1.16B | $1.16B | $1.16B | $1.14B | $1.11B | $1.11B | $1.12B | $1.13B | $1.16B | $1.18B | $1.19B |
| Line item | Aug 1, 2026 | May 2, 2026 | Jan 31, 2026 | Nov 1, 2025 | Aug 2, 2025 | May 3, 2025 | Feb 1, 2025 | Nov 2, 2024 | Aug 3, 2024 | May 4, 2024 | Feb 3, 2024 | Oct 28, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $161.55M | -$30.97M | $153.52M | $90.09M | $85.89M | -$15.45M | $95.99M | $20.72M | $69.37M | -$8.41M | $47.02M | $34.43M |
| Capital expenditures | $31.64M | $38.15M | $37.14M | $29.44M | $32.10M | $28.41M | $36.95M | $31.01M | $27.39M | $32.64M | $49.07M | $62.51M |
| Free cash flow | $129.92M | -$69.12M | $116.39M | $60.65M | $53.79M | -$43.87M | $59.04M | -$10.29M | $41.98M | -$41.05M | -$2.04M | -$28.08M |
| Investing cash flow | -$31.44M | -$37.85M | -$37.14M | -$29.33M | -$30.96M | -$27.13M | -$34.40M | -$31.44M | -$26.32M | -$31.74M | -$51.30M | -$50.33M |
| Financing cash flow | -$3.56M | -$32.64M | -$96.40M | -$1.07M | -$3.95M | -$334.0K | -$952.0K | -$1.91M | -$266.0K | -$5.63M | -$1.31M | -$18.27M |
| Stock-based compensation | $8.60M | $9.45M | $7.28M | $7.16M | $8.79M | $9.42M | $9.51M | $11.36M | $11.91M | $17.43M | $17.43M | $18.18M |
| Depreciation and amortization | $50.40M | $49.04M | $48.24M | $49.30M | $49.36M | $49.81M | $59.10M | $50.11M | $49.72M | $49.59M | $55.02M | $50.67M |
| Line item | Aug 1, 2026 | May 2, 2026 | Jan 31, 2026 | Nov 1, 2025 | Aug 2, 2025 | May 3, 2025 | Feb 1, 2025 | Nov 2, 2024 | Aug 3, 2024 | May 4, 2024 | Feb 3, 2024 | Oct 28, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 0.0% | 0.2% | -2.4% | -3.1% | -2.3% | -2.3% | -7.3% | 1.2% | -0.5% | -1.7% | 6.1% | -0.5% |
| Net income growth, YoY | 176.7% | - | - | - | - | - | - | - | - | - | - | - |
| EPS growth, YoY | 160.0% | - | - | - | - | - | - | - | - | - | - | - |
| Gross margin | 39.7% | 38.4% | 38.3% | 38.9% | 39.3% | 38.2% | 38.0% | 38.1% | 38.1% | 37.8% | 36.2% | 36.8% |
| Operating margin | 3.2% | 1.6% | 2.1% | 2.0% | 2.9% | 1.1% | 1.1% | 0.3% | 0.2% | -1.1% | 0.0% | -82.5% |
| Net margin | 2.6% | -1.0% | -0.2% | 0.6% | 0.9% | -0.8% | -0.9% | -1.1% | -1.6% | -3.0% | -1.3% | -83.1% |
| Free cash flow margin | 8.7% | -4.6% | 7.7% | 4.1% | 3.6% | -2.9% | 3.8% | -0.7% | 2.8% | -2.7% | -0.1% | -1.9% |
| Current ratio | 0.90 | 0.85 | 0.90 | 0.91 | 0.89 | 0.85 | 0.85 | 0.84 | 0.84 | 0.85 | 0.86 | 0.90 |
| Debt to equity | - | - | 1.28 | 1.37 | 1.39 | 1.43 | 1.42 | 1.40 | 1.39 | 1.35 | 1.33 | 1.32 |
Source: XBRL data Petco Health and Wellness Company Inc. files with the SEC, latest filing dated Sep 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| WOOF | $5.97B | -1.3% | $30.27M | 0.5% | $839.2M |
| JD | CN¥1.31T | +13.0% | CN¥19.63B | 1.5% | $38.05B |
| ULTA | $12.96B | +11.2% | $1.21B | 9.3% | $28.41B |
| DKS | $21.15B | +53.5% | $838.83M | 4.0% | $13.34B |
| FCFS | $4.29B | +22.9% | $406.49M | 9.5% | $7.87B |
| BBWI | $7.21B | -2.2% | $781.00M | 10.8% | $4.37B |
| ASO | $6.19B | +3.7% | $395.85M | 6.4% | $4.33B |
| RH | $3.45B | +3.3% | $111.51M | 3.2% | $2.55B |